Overview

Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel are effective and safe in the treatment of papulopustular rosacea.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Medicis Pharmaceutical Corporation
Treatments:
Clindamycin
Clindamycin palmitate
Clindamycin phosphate
Tretinoin